|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 62.88 USD | -7.90% |
|
-17.45% | +114.31% |
| 04:25pm | Moderna advances its cancer therapy assessment, but the stock slides |  |
| 02:07pm | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 81.8 | 81.8 | 79.76 |
| Spread/Res. | -22.74% | -22.74% | -20.76% |
| Spread/Supp. | -1.19% | +5.77% | +39.30% |
| Support | 63.96 | 59.75 | 45.37 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- MRNA Stock
- Charts Moderna, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition